Literature DB >> 31952968

Smoking prevalence among U.S. national samples of pregnant women.

Tyler D Nighbor1, Sulamunn R M Coleman1, Janice Y Bunn2, Allison N Kurti3, Ivori Zvorsky4, Eva J Orr5, Stephen T Higgins6.   

Abstract

Several data sources exist for estimating U.S. smoking prevalence among pregnant women, yet each differs in ways that have the potential to impact the estimates. In the present study we used the Population Assessment of Tobacco and Health (PATH), the National Survey on Drug use and Health (NSDUH), and the Pregnancy Risk Assessment Monitoring System (PRAMS), three common data sources, to evaluate the following questions about estimating U.S. smoking prevalence among pregnant women: To what extent are estimates impacted by differences in whether the samples include younger (<18 years) or older (>44 years) women, represent smoking in any trimester or only the 3rd, and use data from nationally representative or more selected national samples. Among the factors examined, inclusion of younger or older women does not appear to meaningfully alter prevalence estimates. Focusing on only the third trimester likely underestimates smoking prevalence, while the influence of basing estimates on selected national subgroups of women (i.e., only women who delivered live born infants) rather than nationally representative surveys has little discernible influence. Going forward, this research area would benefit from greater consistency in explicitly discussing the sampling methods used and how these various methods may have influenced the estimates reported.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cigarette smoking; National sample; National survey on drug use and health; Population assessment of tobacco and health; Pregnancy; Pregnancy risk assessment monitoring system

Mesh:

Year:  2020        PMID: 31952968      PMCID: PMC7024639          DOI: 10.1016/j.ypmed.2020.105994

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  13 in total

1.  Mental health problems, legal involvement, and smoking during pregnancy.

Authors:  Lisa M Kratz; Ellen L Vaughan
Journal:  Subst Use Misuse       Date:  2012-03-12       Impact factor: 2.164

2.  Estimates of smoking before and during pregnancy, and smoking cessation during pregnancy: comparing two population-based data sources.

Authors:  Van T Tong; Patricia M Dietz; Sherry L Farr; Denise V D'Angelo; Lucinda J England
Journal:  Public Health Rep       Date:  2013 May-Jun       Impact factor: 2.792

3.  The Pregnancy Risk Assessment Monitoring System (PRAMS): Overview of Design and Methodology.

Authors:  Holly B Shulman; Denise V D'Angelo; Leslie Harrison; Ruben A Smith; Lee Warner
Journal:  Am J Public Health       Date:  2018-08-23       Impact factor: 9.308

4.  Tobacco and nicotine delivery product use in a national sample of pregnant women.

Authors:  Allison N Kurti; Ryan Redner; Alexa A Lopez; Diana R Keith; Andrea C Villanti; Cassandra A Stanton; Diann E Gaalema; Janice Y Bunn; Nathan J Doogan; Antonio Cepeda-Benito; Megan E Roberts; Julie Phillips; Stephen T Higgins
Journal:  Prev Med       Date:  2017-08-05       Impact factor: 4.018

5.  Use of higher-nicotine/tar-yield (regular full-flavor) cigarettes is associated with nicotine dependence and smoking during pregnancy among U.S. women.

Authors:  Stephen T Higgins; Ryan Redner; Christopher A Arger; Allison N Kurti; Jeff S Priest; Janice Y Bunn
Journal:  Prev Med       Date:  2017-08-05       Impact factor: 4.018

6.  Infant morbidity and mortality attributable to prenatal smoking in the U.S.

Authors:  Patricia M Dietz; Lucinda J England; Carrie K Shapiro-Mendoza; Van T Tong; Sherry L Farr; William M Callaghan
Journal:  Am J Prev Med       Date:  2010-07       Impact factor: 5.043

7.  Reliability of Reported Maternal Smoking: Comparing the Birth Certificate to Maternal Worksheets and Prenatal and Hospital Medical Records, New York City and Vermont, 2009.

Authors:  Renata E Howland; Candace Mulready-Ward; Ann M Madsen; Judith Sackoff; Michael Nyland-Funke; Jennifer M Bombard; Van T Tong
Journal:  Matern Child Health J       Date:  2015-09

8.  Births: Final Data for 2017.

Authors:  Joyce A Martin; Brady E Hamilton; Michelle J K Osterman; Anne K Driscoll; Patrick Drake
Journal:  Natl Vital Stat Rep       Date:  2018-11

9.  Trends in smoking before, during, and after pregnancy--Pregnancy Risk Assessment Monitoring System, United States, 40 sites, 2000-2010.

Authors:  Van T Tong; Patricia M Dietz; Brian Morrow; Denise V D'Angelo; Sherry L Farr; Karilynn M Rockhill; Lucinda J England
Journal:  MMWR Surveill Summ       Date:  2013-11-08

10.  Social determinants of smoke exposure during pregnancy: Findings from waves 1 & 2 of the Population Assessment of Tobacco and Health (PATH) Study.

Authors:  Elizabeth K Do; Tiffany L Green; Elizabeth C Prom-Wormley; Bernard F Fuemmeler
Journal:  Prev Med Rep       Date:  2018-10-28
View more
  4 in total

1.  Patterns and Trends in Use of Electronic Nicotine Delivery Systems Before and During Pregnancy: Pregnancy Risk Assessment Monitoring System, United States, 2016-2019.

Authors:  Sara K Head; Ibrahim Zaganjor; Justina N Kofie; Michael D Sawdey; Karen A Cullen
Journal:  J Community Health       Date:  2022-01-13

2.  Smartphone-based financial incentives to promote smoking cessation during pregnancy: A pilot study.

Authors:  Allison N Kurti; Katherine Tang; Hypatia A Bolivar; Carolyn Evemy; Norman Medina; Joan Skelly; Tyler Nighbor; Stephen T Higgins
Journal:  Prev Med       Date:  2020-07-09       Impact factor: 4.018

3.  Maternal Smoking and Congenital Heart Defects, National Birth Defects Prevention Study, 1997-2011.

Authors:  Elijah H Bolin; Yevgeniya Gokun; Paul A Romitti; Sarah C Tinker; April D Summers; Paula K Roberson; Charlotte A Hobbs; Sadia Malik; Lorenzo D Botto; Wendy N Nembhard
Journal:  J Pediatr       Date:  2021-09-08       Impact factor: 4.406

4.  Decreasing smoking during pregnancy: Potential economic benefit of reducing sudden unexpected infant death.

Authors:  Stephen T Higgins; Eric P Slade; Donald S Shepard
Journal:  Prev Med       Date:  2020-08-17       Impact factor: 4.018

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.